
Sofokast Plus is an oral antiviral medication combining Sofosbuvir 400 mg and Daclatasvir 60 mg, used in treating chronic hepatitis C virus (HCV) infection.
| Generic Name | Sofosbuvir 400 mg and Daclatasvir 60 mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | HCV Infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
Dr. Alka Yadav Jain is a qualified physician with professional experience in viral infection care and medication management. Her areas of interest include antiviral therapies, responsible prescribing, monitoring treatment response and supporting the safe use of medicines.